Quest Diagnostics Incorporated (NYSE:DGX) Q1 2025 Earnings Call Transcript
Operator: Welcome to the Quest Diagnostics First Quarter 2025 Conference Call. At the request of the company, this call is being recorded.
Quest Diagnostics Inc (DGX)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Marshall Wace LLP Paul Marshall And Ian Wace | 483,287 | $81,772,161 | -40% | 0.1% |
| 2. | Woodline Partners Michael Rockefeller And Karl Kroeker | 380,700 | $64,414,440 | -25% | 0.42% |
| 3. | 280,300 | $47,426,760 | +181% | 0.03% | |
| 4. | Balyasny Asset Management Dmitry Balyasny | 207,256 | $35,067,715 | +85% | 0.06% |
| 5. | Squarepoint Ops LLC Maxime Fortin (Cio) | 154,994 | $26,224,985 | +4837% | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $55.51 | 4,000 | $222,023.20 | 44,222 | 2014-05-05 | Filing | |
| $50.71 | 2,600 | $131,846.00 | 5,658 | 2014-02-06 | Filing | |
| $50.70 | 2,400 | $121,680.00 | 3,058 | 2014-02-06 | Filing | |
| $59.34 | 5,000 | $296,676.50 | 68,034 | 2012-08-07 | Filing | |
| $56.89 | 20,000 | $1,137,748.00 | 63,034 | 2012-05-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $175.31 | 874 | $153,220.94 | 7,498 | 2025-05-13 | Filing | |
| $175.72 | 874 | $153,579.28 | 8,372 | 2025-05-12 | Filing | |
| $169.63 | 453 | $76,844.20 | 127,623 | 2025-04-02 | Filing | |
| $168.79 | 902 | $152,249.48 | 128,076 | 2025-04-02 | Filing | |
| $167.88 | 1,493 | $250,642.75 | 128,978 | 2025-04-02 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,619 | $470,451 | 0.04% | |
| 2. | 73 | $13,113 | 0% |
News See All
Quest Diagnostics Incorporated (DGX): A Bull Case Theory
We came across a bullish thesis on Quest Diagnostics Incorporated (DGX) on Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on DGX.
Top 8 AI News Updates Investors Shouldn’t Miss
On March 19th, the stock market bounced back after the US Federal Reserve kept interest rates unchanged at 4.25% to 4.5%. The Fed also anticipated two rate cuts this year despite elevated inflation.
Quest Diagnostics Incorporated (NYSE:DGX) Q4 2024 Earnings Call Transcript
Operator: Welcome to the Quest Diagnostics Fourth Quarter and Full-Year 2024 Conference Call. At the request of the company, this call is being recorded.
8 Most Undervalued Pot Stocks to Buy According to Analysts
A decade ago, the cannabis industry was in full swing as stock valuations exploded to record highs in states across the country legalizing pot use for medicinal and recreational purposes.
Quest Diagnostics Incorporated (NYSE:DGX) Q3 2024 Earnings Call Transcript
Operator: Welcome to the Quest Diagnostics Third Quarter 2024 conference call. At the request of the company, this call is being recorded.
Quest Diagnostics Incorporated (NYSE:DGX) Q2 2024 Earnings Call Transcript
Operator: Welcome to the Quest Diagnostics Second Quarter 2024 conference call. At the request of the company, this call is being recorded.
Is Quest Diagnostics Incorporated (DGX) an Undervalued High Growth Stock?
Fiduciary Management Inc. (FMI), an independent money management firm, released its second quarter 2024 investor letter.
Quest Diagnostics Incorporated (NYSE:DGX) Q1 2024 Earnings Call Transcript
Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is $2.04, expectations were $1.86.
Quest Diagnostics Incorporated (NYSE:DGX) Q4 2023 Earnings Call Transcript
Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is $2.15, expectations were $2.14.
Billionaire Hedge Funds
